Tuula Salo Selected Research

CTTHWGFTLC peptide

5/2006	Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides.
3/2002	Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tuula Salo Research Topics

Disease

92	Neoplasms (Cancer) 05/2022 - 05/2003
42	Squamous Cell Carcinoma of Head and Neck 05/2022 - 02/2008
34	Carcinoma (Carcinomatosis) 01/2022 - 06/2003
20	Neoplasm Metastasis (Metastasis) 03/2022 - 03/2002
15	Carcinogenesis 07/2021 - 07/2003
15	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020 - 06/2003
14	Mouth Neoplasms (Oral Cancer) 05/2022 - 11/2006
14	Inflammation (Inflammations) 12/2020 - 01/2006
11	Tongue Neoplasms (Tongue Neoplasm) 11/2020 - 07/2010
11	Myoma 10/2018 - 09/2009
7	Wounds and Injuries (Trauma) 03/2022 - 01/2002
5	Lymphatic Metastasis 05/2022 - 01/2013
5	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 03/2011
5	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2012
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 12/2019
4	Oral Lichen Planus 04/2019 - 07/2015
4	Periodontitis 02/2009 - 08/2003
3	Sepsis (Septicemia) 03/2022 - 01/2017
3	Leiomyoma (Uterine Fibroids) 01/2020 - 01/2014
3	Hypoxia (Hypoxemia) 01/2015 - 01/2012
3	Peri-Implantitis 02/2008 - 12/2003
2	Breast Neoplasms (Breast Cancer) 04/2022 - 07/2002
2	Mucoepidermoid Carcinoma 01/2021 - 03/2011
2	Lung Neoplasms (Lung Cancer) 01/2017 - 11/2012
2	Aggressive Periodontitis (Periodontosis) 08/2014 - 02/2008
2	Lymphoma (Lymphomas) 02/2014 - 11/2007
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2014 - 11/2007
2	Leukemia 02/2014 - 11/2007

Drug/Important Bio-Agent (IBA)

31	Matrix Metalloproteinases (MMPs)IBA 11/2019 - 03/2002
15	Proteins (Proteins, Gene)FDA Link 05/2022 - 05/2003
15	CollagenIBA 05/2021 - 01/2002
11	Biomarkers (Surrogate Marker)IBA 05/2022 - 09/2010
11	CytokinesIBA 01/2022 - 01/2006
8	Collagen Type I (Type I Collagen)IBA 12/2020 - 05/2003
8	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 09/2017 - 11/2002
7	Messenger RNA (mRNA)IBA 01/2022 - 02/2003
7	Peptides (Polypeptides)IBA 01/2018 - 07/2005
6	Pharmaceutical PreparationsIBA 07/2021 - 03/2014
6	EnzymesIBA 12/2020 - 01/2006
6	GelatinasesIBA 11/2011 - 05/2006
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2022 - 05/2006
5	Interleukin-17 (Interleukin 17)IBA 01/2022 - 02/2016
5	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2020 - 04/2015
5	Collagen Type XVIII (Type XVIII Collagen)IBA 08/2015 - 06/2003
5	Peptide Hydrolases (Proteases)FDA Link 07/2014 - 02/2008
5	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2012 - 11/2002
4	FibrinIBA 01/2022 - 01/2019
4	Fibronectins (Fibronectin)IBA 01/2020 - 03/2002
4	matrigelIBA 12/2019 - 03/2002
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019 - 09/2003
4	KalininIBA 01/2017 - 01/2002
4	Tissue Inhibitor of Metalloproteinase-1IBA 08/2014 - 07/2010
4	Matrix Metalloproteinase InhibitorsIBA 11/2011 - 01/2006
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 03/2022 - 03/2014
3	fascinIBA 12/2021 - 01/2020
3	Histamine (Histamine Dihydrochloride)FDA Link 07/2021 - 12/2017
3	AntibodiesIBA 01/2021 - 01/2007
3	Angiogenesis InhibitorsIBA 01/2021 - 01/2012
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2017
3	activin AIBA 01/2020 - 09/2011
3	Histamine H4 ReceptorsIBA 01/2020 - 12/2017
3	CurcuminIBA 09/2018 - 03/2013
3	Protein Isoforms (Isoforms)IBA 02/2018 - 12/2004
3	IntegrinsIBA 01/2017 - 01/2012
3	LigandsIBA 09/2015 - 06/2013
3	EndostatinsIBA 08/2015 - 06/2003
3	Green Fluorescent ProteinsIBA 02/2014 - 08/2010
3	Serine Proteases (Serine Protease)IBA 10/2012 - 05/2003
3	ClaudinsIBA 03/2011 - 01/2007
3	enamel matrix proteinsIBA 12/2010 - 08/2008
2	Hyaluronan ReceptorsIBA 01/2022 - 03/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 08/2006
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	medicagenic acid-3-O-glucopyranosideIBA 12/2021 - 01/2020
2	Peroxidase (Myeloperoxidase)IBA 01/2021 - 10/2014
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
2	Conditioned Culture MediaIBA 09/2020 - 09/2011
2	Glycoproteins (Glycoprotein)IBA 02/2020 - 01/2020
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 11/2019 - 02/2013
2	Indicators and Reagents (Reagents)IBA 05/2019 - 02/2009
2	DefensinsIBA 04/2019 - 12/2003
2	heparanaseIBA 10/2018 - 01/2014
2	Oncogene Proteins (Oncogene Protein)IBA 02/2018 - 03/2014
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2017 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 08/2006
2	Collagen Type XVIIIBA 01/2017 - 07/2003
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 10/2014
2	Bromodeoxyuridine (BrdU)IBA 01/2017 - 04/2015
2	Laminin (Merosin)IBA 01/2017 - 12/2004
2	Cathepsin KIBA 11/2016 - 01/2013
2	Toll-Like Receptor 9IBA 09/2015 - 08/2014
2	Doxycycline (Periostat)FDA LinkGeneric 04/2015 - 01/2006
2	Biological ProductsIBA 08/2014 - 02/2014
2	Collagenases (Collagenase)FDA Link 07/2013 - 02/2012

Therapy/Procedure

17	Therapeutics 01/2022 - 11/2007
3	Neck Dissection (Radical Neck Dissection) 11/2019 - 03/2014
2	Molecular Targeted Therapy 01/2020 - 11/2012
2	Precision Medicine 11/2019 - 10/2019
2	Immunotherapy 10/2019 - 09/2019